DiagnoCure diagnostic news

DiagnoCure adopted a shareholder rights plan to protect shareholders in the event of a takeover bid. Under the plan, each current and subsequently issued share of common stock will have a right attached to it that will become exercisable if any party acquires more than 20% of the company's outstanding shares without complying with the permitted bid provisions of the rights plan. The right is exercisable at a 50% discount to market prices. The company said the plan is not in response to any specific proposal to acquire the company and is subject to shareholder approval at an annual meeting to be held March 11. ...